GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	720.53	686.28	621.73	515.67	392.44	260.45
Other Revenue	0.73	0.56	0.45	0.87	1.34	1.47
Revenue	721.26	686.84	622.19	516.55	393.79	261.92
Revenue Growth (YoY)	8.18%	10.39%	20.45%	31.17%	50.35%	35.91%
Cost of Revenue	274.24	261.33	202.86	150.22	101.27	73.99
Gross Profit	447.02	425.51	419.33	366.33	292.51	187.92
Selling, General & Admin	246.12	239.68	199.61	174.76	134.42	79.43
Research & Development	85.53	87.13	96.6	82.93	55.2	48.22
Other Operating Expenses	20.18	3.57	2.61	1.72	1.59	-36.65
Operating Expenses	356.05	333.68	307.91	267.94	196.11	94.35
Operating Income	90.97	91.83	111.42	98.39	96.4	93.57
Interest Expense	-4.94	-4.3	-2.76	-0.5	-0.74	-0.72
Interest & Investment Income	14.45	22.39	28.65	23.73	14.43	7.91
Currency Exchange Gain (Loss)	3.56	1.69	0.08	1.49	-0.19	-0.76
Other Non Operating Income (Expenses)	-17.19	-21.56	-20.92	-11.32	-16.05	-8.64
EBT Excluding Unusual Items	86.85	90.06	116.48	111.8	93.84	91.35
Gain (Loss) on Sale of Investments	0.34	2.34	2.73	-0.05	0.32	-
Gain (Loss) on Sale of Assets	-0.01	0.01	-0.02	-0.1	0.05	-
Other Unusual Items	32.07	26.8	42.1	62.03	49.1	-
Pretax Income	119.25	119.22	161.29	173.68	143.31	91.35
Income Tax Expense	14.86	9.4	2.37	9.02	18.39	14.92
Earnings From Continuing Operations	104.39	109.82	158.91	164.67	124.93	76.43
Net Income	104.39	109.82	158.91	164.67	124.93	76.43
Net Income to Common	104.39	109.82	158.91	164.67	124.93	76.43
Net Income Growth	-33.80%	-30.89%	-3.49%	31.81%	63.45%	152.21%
Shares Outstanding (Basic)	414	407	407	392	357	364
Shares Outstanding (Diluted)	414	407	407	392	357	364
Shares Change (YoY)	2.51%	-0.18%	3.93%	9.84%	-1.93%	-
EPS (Basic)	0.25	0.27	0.39	0.42	0.35	0.21
EPS (Diluted)	0.25	0.27	0.39	0.42	0.35	0.21
EPS Growth	-35.42%	-30.77%	-7.14%	20.00%	66.67%	-
Free Cash Flow	37.41	-23.36	-89.33	-84.33	24.24	-37.28
Free Cash Flow Per Share	0.09	-0.06	-0.22	-0.21	0.07	-0.10
Dividend Per Share	0.140	0.140	0.160	0.041	-	-
Dividend Growth	-26.32%	-12.50%	290.24%	-	-	-
Gross Margin	61.98%	61.95%	67.40%	70.92%	74.28%	71.75%
Operating Margin	12.61%	13.37%	17.91%	19.05%	24.48%	35.73%
Profit Margin	14.47%	15.99%	25.54%	31.88%	31.72%	29.18%
Free Cash Flow Margin	5.19%	-3.40%	-14.36%	-16.33%	6.16%	-14.23%
EBITDA	163.61	164.62	157.42	135.68	125.2	110.41
EBITDA Margin	22.68%	23.97%	25.30%	26.27%	31.80%	42.15%
D&A For EBITDA	72.64	72.79	46	37.29	28.81	16.83
EBIT	90.97	91.83	111.42	98.39	96.4	93.57
EBIT Margin	12.61%	13.37%	17.91%	19.05%	24.48%	35.73%
Effective Tax Rate	12.46%	7.88%	1.47%	5.19%	12.83%	16.33%
Revenue as Reported	721.26	686.84	622.19	516.55	393.79	-
Advertising Expenses	-	2.93	4.69	8.94	2.87	2.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.